_id
691301f1ccc777a4e85d7967
Ticker
INKT
Name
Mink Therapeutics Inc
Exchange
NASDAQ
Address
149 Fifth Avenue, New York, NY, United States, 10010
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://minktherapeutics.com
Description
MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company develops agenT-797, an off-the-shelf, allogeneic, and native iNKT cell therapy that is in Phase 2 clinical trial for the clinical safety and efficacy of the combination of agenT-797, botensilimab plus balstilimab with ramucirumab and paclitaxel for patients with previously treated, advanced esophageal, gastric, or gastro-esophageal junction adenocarcinoma; Phase 1 trial as a monotherapy in combination with anti-PD-1 checkpoint inhibitors, pembrolizumab, and nivolumab for refractory solid tumor cancers; and Phase 1 trial for the treatment of moderate to severe viral acute respiratory distress syndrome. It is also developing MiNK-215, an IL-15 armored tumor stromal targeting the FAP-CAR-iNKT program to treat solid tumors and inflammation; and MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen for auto-immune diseases. The company has collaborations with Autonomous Therapeutics to target and treat metastatic tumors; and ImmunoScape, Inc. to discover and develop T-cell receptor therapies against targets in solid tumors. The company was formerly known as AgenTus Therapeutics, Inc. and changed its name to MiNK Therapeutics, Inc. in June 2021. The company was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Last Close
12.55
Volume
9076
Current Price
12.42
Change
-1.0358565737051855
Last Updated
2025-12-01T09:21:20.920Z
Image
data:image/webp;base64,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
Ipo Date
2021-10-15T00:00:00.000Z
Market Cap
49335572
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.20339999999999997
Sentiment Sources
5
Rating
4.6667
Target Price
39
Strong Buy
2
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
43654
Gross Profit
-43654
Operating Expenses
2946019
Operating Income
-2989673
Interest Expense
-
Pretax Income
-2887709
Net Income
-2887709
Eps
-0.6499457573711456
Dividends Per Share
-
Shares Outstanding
4694155
Income Tax Expense
-
EBITDA
-2844059
Operating Margin
-
Total Other Income Expense Net
101964
Cash
14281212
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
14534321
Property Plant Equipment
429344
Total Assets
14963665
Payables
3693115
Short Term Debt
5725267
Long Term Debt
-
Total Liabilities
28476647
Equity
-13512982
Depreciation
43654
Change In Working Capital
1061014
Cash From Operations
-941348
Capital Expenditures
2
Cash From Investing
-
Cash From Financing
13545678
Net Change In Cash
12599297
PE
-
PB
-4.083633057455416
ROE
21.369887120400218
ROA
-19.29813986078945
FCF
-941350
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
43654
Quarters > 0 > income Statement > gross Profit
-43654
Quarters > 0 > income Statement > operating Expenses
2946019
Quarters > 0 > income Statement > operating Income
-2989673
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2887709
Quarters > 0 > income Statement > net Income
-2887709
Quarters > 0 > income Statement > eps
-0.6499457573711456
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4443000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2844059
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
101964
Quarters > 0 > balance Sheet > cash
14281212
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
14534321
Quarters > 0 > balance Sheet > property Plant Equipment
429344
Quarters > 0 > balance Sheet > total Assets
14963665
Quarters > 0 > balance Sheet > payables
3693115
Quarters > 0 > balance Sheet > short Term Debt
5725267
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
28476647
Quarters > 0 > balance Sheet > equity
-13512982
Quarters > 0 > cash Flow > net Income
-2887709
Quarters > 0 > cash Flow > depreciation
43654
Quarters > 0 > cash Flow > change In Working Capital
1061014
Quarters > 0 > cash Flow > cash From Operations
-941348
Quarters > 0 > cash Flow > capital Expenditures
2
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
13545678
Quarters > 0 > cash Flow > net Change In Cash
12599297
Quarters > 0 > ratios > PE
-0.6499457573711456
Quarters > 0 > ratios > PB
-4.083633057455416
Quarters > 0 > ratios > ROE
21.369887120400218
Quarters > 0 > ratios > ROA
-19.29813986078945
Quarters > 0 > ratios > FCF
-941350
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
48763
Quarters > 1 > income Statement > gross Profit
-48763
Quarters > 1 > income Statement > operating Expenses
3639543
Quarters > 1 > income Statement > operating Income
-3688306
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-4237751
Quarters > 1 > income Statement > net Income
-4237751
Quarters > 1 > income Statement > eps
-1.0642289085462753
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3981992
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4188985
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-549445
Quarters > 1 > balance Sheet > cash
1681915
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2011202
Quarters > 1 > balance Sheet > property Plant Equipment
473215
Quarters > 1 > balance Sheet > total Assets
2484417
Quarters > 1 > balance Sheet > payables
3314839
Quarters > 1 > balance Sheet > short Term Debt
5506346
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
27673732
Quarters > 1 > balance Sheet > equity
-25189315
Quarters > 1 > cash Flow > net Income
-4237751
Quarters > 1 > cash Flow > depreciation
48763
Quarters > 1 > cash Flow > change In Working Capital
1167303
Quarters > 1 > cash Flow > cash From Operations
-1569218
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
540
Quarters > 1 > cash Flow > net Change In Cash
-1552984
Quarters > 1 > ratios > PE
-1.0642289085462753
Quarters > 1 > ratios > PB
-1.9633856911154592
Quarters > 1 > ratios > ROE
16.82360556450225
Quarters > 1 > ratios > ROA
-170.573257226947
Quarters > 1 > ratios > FCF
-1569218
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
36
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
50765
Quarters > 2 > income Statement > gross Profit
-50765
Quarters > 2 > income Statement > operating Expenses
2482000
Quarters > 2 > income Statement > operating Income
-2532765
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2766697
Quarters > 2 > income Statement > net Income
-2766697
Quarters > 2 > income Statement > eps
-0.6977829911964292
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3964982
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2715935
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-233932
Quarters > 2 > balance Sheet > cash
3234899
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3579813
Quarters > 2 > balance Sheet > property Plant Equipment
687500
Quarters > 2 > balance Sheet > total Assets
4267313
Quarters > 2 > balance Sheet > payables
2661195
Quarters > 2 > balance Sheet > short Term Debt
5117534
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
26059092
Quarters > 2 > balance Sheet > equity
-21791779
Quarters > 2 > cash Flow > net Income
-2766697
Quarters > 2 > cash Flow > depreciation
50765
Quarters > 2 > cash Flow > change In Working Capital
591045
Quarters > 2 > cash Flow > cash From Operations
-1340876000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
576000
Quarters > 2 > cash Flow > net Change In Cash
-1342141000
Quarters > 2 > ratios > PE
-0.6977829911964292
Quarters > 2 > ratios > PB
-2.2598006541824787
Quarters > 2 > ratios > ROE
12.696058453970188
Quarters > 2 > ratios > ROA
-64.83463950265659
Quarters > 2 > ratios > FCF
-1340876000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3769421862
Quarters > 3 > income Statement > cost Of Revenue
53869
Quarters > 3 > income Statement > gross Profit
-53869
Quarters > 3 > income Statement > operating Expenses
2161131
Quarters > 3 > income Statement > operating Income
-2215000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2464000
Quarters > 3 > income Statement > net Income
-2464000
Quarters > 3 > income Statement > eps
-0.6530048026595104
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3773326
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2410129
Quarters > 3 > income Statement > operating Margin
-0.05876232698519856
Quarters > 3 > income Statement > total Other Income Expense Net
-249000
Quarters > 3 > balance Sheet > cash
4577040
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
4987884
Quarters > 3 > balance Sheet > property Plant Equipment
732929
Quarters > 3 > balance Sheet > total Assets
5720813
Quarters > 3 > balance Sheet > payables
2728212
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
4924612
Quarters > 3 > balance Sheet > total Liabilities
25306695
Quarters > 3 > balance Sheet > equity
-19585882
Quarters > 3 > cash Flow > net Income
-2463104
Quarters > 3 > cash Flow > depreciation
53869
Quarters > 3 > cash Flow > change In Working Capital
-21449
Quarters > 3 > cash Flow > cash From Operations
-1727667
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-3
Quarters > 3 > cash Flow > net Change In Cash
-1751199
Quarters > 3 > ratios > PE
-0.6530048026595104
Quarters > 3 > ratios > PB
-2.392780111715163
Quarters > 3 > ratios > ROE
12.580490375669577
Quarters > 3 > ratios > ROA
-43.070801300444536
Quarters > 3 > ratios > FCF
-1727667
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.00045833739582635234
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
215437
Annuals > 0 > income Statement > gross Profit
-215437
Annuals > 0 > income Statement > operating Expenses
10434802
Annuals > 0 > income Statement > operating Income
-10650239
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-10784802
Annuals > 0 > income Statement > net Income
-10784802
Annuals > 0 > income Statement > eps
-2.7915688672105126
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3863348
Annuals > 0 > income Statement > income Tax Expense
-10774017198
Annuals > 0 > income Statement > EBITDA
-10569369
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-134563
Annuals > 0 > balance Sheet > cash
4577040
Annuals > 0 > balance Sheet > short Term Investments
4572462960
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4987884
Annuals > 0 > balance Sheet > property Plant Equipment
732929
Annuals > 0 > balance Sheet > total Assets
5720813
Annuals > 0 > balance Sheet > payables
2728212
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
4924612
Annuals > 0 > balance Sheet > total Liabilities
25306695
Annuals > 0 > balance Sheet > equity
-19585882
Annuals > 0 > cash Flow > net Income
-10784802
Annuals > 0 > cash Flow > depreciation
215437
Annuals > 0 > cash Flow > change In Working Capital
459728
Annuals > 0 > cash Flow > cash From Operations
-9555476
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
10819986
Annuals > 0 > cash Flow > net Change In Cash
1209811
Annuals > 0 > ratios > PE
-2.7915688672105126
Annuals > 0 > ratios > PB
-2.073115087694289
Annuals > 0 > ratios > ROE
55.06416305377516
Annuals > 0 > ratios > ROA
-188.51869480788832
Annuals > 0 > ratios > FCF
-9555480
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
204617
Annuals > 1 > income Statement > gross Profit
-204617
Annuals > 1 > income Statement > operating Expenses
22716488
Annuals > 1 > income Statement > operating Income
-22921105
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-22457859
Annuals > 1 > income Statement > net Income
-22457859
Annuals > 1 > income Statement > eps
-6.536058852256436
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3435994
Annuals > 1 > income Statement > income Tax Expense
3
Annuals > 1 > income Statement > EBITDA
-22253242
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
463246
Annuals > 1 > balance Sheet > cash
3367229
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3598304
Annuals > 1 > balance Sheet > property Plant Equipment
953977
Annuals > 1 > balance Sheet > total Assets
4552281
Annuals > 1 > balance Sheet > payables
3911973
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
22607730
Annuals > 1 > balance Sheet > equity
-18055449
Annuals > 1 > cash Flow > net Income
-22457859
Annuals > 1 > cash Flow > depreciation
204617
Annuals > 1 > cash Flow > change In Working Capital
2897144
Annuals > 1 > cash Flow > cash From Operations
-15762512
Annuals > 1 > cash Flow > capital Expenditures
73561
Annuals > 1 > cash Flow > cash From Investing
-73561
Annuals > 1 > cash Flow > cash From Financing
-407173
Annuals > 1 > cash Flow > net Change In Cash
-16268496
Annuals > 1 > ratios > PE
-6.536058852256436
Annuals > 1 > ratios > PB
-2.0000774802110985
Annuals > 1 > ratios > ROE
124.38272235711226
Annuals > 1 > ratios > ROA
-493.33200213255725
Annuals > 1 > ratios > FCF
-15836073
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2704743000
Annuals > 2 > income Statement > cost Of Revenue
121749
Annuals > 2 > income Statement > gross Profit
-121749
Annuals > 2 > income Statement > operating Expenses
30827529
Annuals > 2 > income Statement > operating Income
-30949278
Annuals > 2 > income Statement > interest Expense
253323
Annuals > 2 > income Statement > pretax Income
-27991212
Annuals > 2 > income Statement > net Income
-27991212
Annuals > 2 > income Statement > eps
-8.312677368045302
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3367292
Annuals > 2 > income Statement > income Tax Expense
-3211389
Annuals > 2 > income Statement > EBITDA
-27869466
Annuals > 2 > income Statement > operating Margin
-1.1442594730811761
Annuals > 2 > income Statement > total Other Income Expense Net
2958066
Annuals > 2 > balance Sheet > cash
19635725
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
20404692
Annuals > 2 > balance Sheet > property Plant Equipment
1066910
Annuals > 2 > balance Sheet > total Assets
21471602
Annuals > 2 > balance Sheet > payables
5823000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
21872905
Annuals > 2 > balance Sheet > equity
-401303
Annuals > 2 > cash Flow > net Income
-27991212
Annuals > 2 > cash Flow > depreciation
121749
Annuals > 2 > cash Flow > change In Working Capital
8766583
Annuals > 2 > cash Flow > cash From Operations
-18866843
Annuals > 2 > cash Flow > capital Expenditures
250046
Annuals > 2 > cash Flow > cash From Investing
-250046
Annuals > 2 > cash Flow > cash From Financing
-155599
Annuals > 2 > cash Flow > net Change In Cash
-19253103
Annuals > 2 > ratios > PE
-8.312677368045302
Annuals > 2 > ratios > PB
-88.18832383510713
Annuals > 2 > ratios > ROE
6975.081671455235
Annuals > 2 > ratios > ROA
-130.36387317536904
Annuals > 2 > ratios > FCF
-19116889
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.007067913291577055
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
77960
Annuals > 3 > income Statement > gross Profit
-77960
Annuals > 3 > income Statement > operating Expenses
18528336
Annuals > 3 > income Statement > operating Income
-18606296
Annuals > 3 > income Statement > interest Expense
2431614
Annuals > 3 > income Statement > pretax Income
-30212770
Annuals > 3 > income Statement > net Income
-30212770
Annuals > 3 > income Statement > eps
-9.025062939636497
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3347652
Annuals > 3 > income Statement > income Tax Expense
-7098761
Annuals > 3 > income Statement > EBITDA
-27703196
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-11606474
Annuals > 3 > balance Sheet > cash
38888828
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
23000
Annuals > 3 > balance Sheet > inventories
1761
Annuals > 3 > balance Sheet > total Current Assets
39634910
Annuals > 3 > balance Sheet > property Plant Equipment
606595
Annuals > 3 > balance Sheet > total Assets
40241505
Annuals > 3 > balance Sheet > payables
2995645
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
16465036
Annuals > 3 > balance Sheet > equity
23776469
Annuals > 3 > cash Flow > net Income
-30212770
Annuals > 3 > cash Flow > depreciation
77960
Annuals > 3 > cash Flow > change In Working Capital
3736122
Annuals > 3 > cash Flow > cash From Operations
-12827117
Annuals > 3 > cash Flow > capital Expenditures
248983
Annuals > 3 > cash Flow > cash From Investing
-248983
Annuals > 3 > cash Flow > cash From Financing
49256873
Annuals > 3 > cash Flow > net Change In Cash
36197672
Annuals > 3 > ratios > PE
-9.025062939636497
Annuals > 3 > ratios > PB
1.479774920321432
Annuals > 3 > ratios > ROE
-127.07004559844441
Annuals > 3 > ratios > ROA
-75.07862839622922
Annuals > 3 > ratios > FCF
-13076100
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.6499457573711456
Valuation > metrics > PB
-4.083633057455416
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
21.369887120400218
Profitability > metrics > ROA
-19.868207121612354
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-68.49193585337915
Risk > final Score
-244
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.543186611033615
Liquidity > metrics > Quick Ratio
1.543186611033615
Liquidity > final Score
89
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
49
Prev Profitabilities > 1
40
Prev Profitabilities > 2
25
Prev Risks > 0
-273
Prev Risks > 1
-170
Prev Risks > 2
-134
Prev Liquidities > 0
21
Prev Liquidities > 1
33
Prev Liquidities > 2
96
Updated At
2025-12-14T00:40:26.011Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.65
Earnings History > 0 > eps Estimate
-0.07
Earnings History > 0 > eps Difference
-0.58
Earnings History > 0 > surprise Percent
-828.5714
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.06
Earnings History > 1 > eps Estimate
-0.065
Earnings History > 1 > eps Difference
-0.995
Earnings History > 1 > surprise Percent
-1530.7692
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.7
Earnings History > 2 > eps Estimate
-0.15
Earnings History > 2 > eps Difference
-0.55
Earnings History > 2 > surprise Percent
-366.6667
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-18
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.62
Earnings History > 3 > eps Estimate
-0.08
Earnings History > 3 > eps Difference
-0.54
Earnings History > 3 > surprise Percent
-675
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.05
Earnings History > 4 > eps Estimate
-0.0801
Earnings History > 4 > eps Difference
0.0301
Earnings History > 4 > surprise Percent
37.578
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0727
Earnings History > 5 > eps Estimate
-0.1
Earnings History > 5 > eps Difference
0.0273
Earnings History > 5 > surprise Percent
27.3
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
-0.15
Earnings History > 6 > eps Difference
0.04
Earnings History > 6 > surprise Percent
26.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-21
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.16
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-6.6667
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.15
Earnings History > 8 > eps Estimate
-0.18
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
16.6667
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.18
Earnings History > 9 > eps Estimate
-0.2
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
10
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.17
Earnings History > 10 > eps Estimate
-0.24
Earnings History > 10 > eps Difference
0.07
Earnings History > 10 > surprise Percent
29.1667
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-21
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.21
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-9.5238
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.19
Earnings History > 12 > eps Estimate
-0.23
Earnings History > 12 > eps Difference
0.04
Earnings History > 12 > surprise Percent
17.3913
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.18
Earnings History > 13 > eps Estimate
-0.24
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
25
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.23
Earnings History > 14 > eps Estimate
-0.21
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-9.5238
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-18
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.18
Earnings History > 15 > eps Estimate
-0.41
Earnings History > 15 > eps Difference
0.23
Earnings History > 15 > surprise Percent
56.0976
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-29
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.59
Earnings History > 16 > eps Estimate
-0.2
Earnings History > 16 > eps Difference
-0.39
Earnings History > 16 > surprise Percent
-195
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-01
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.21
Earnings History > 17 > eps Estimate
-0.28
Earnings History > 17 > eps Difference
0.07
Earnings History > 17 > surprise Percent
25
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.2106
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.2106
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.2106
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.2106
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.157
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.157
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.157
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.157
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.1798
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.1798
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.1798
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.1798
Earnings History > 23 > surprise Percent
-
MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company develops agenT-797, an off-the-shelf, allogeneic, and native iNKT cell therapy that is in Phase 2 clinical trial for the clinical safety and efficacy of the combination of agenT-797, botensilimab plus balstilimab with ramucirumab and paclitaxel for patients with previously treated, advanced esophageal, gastric, or gastro-esophageal junction adenocarcinoma; Phase 1 trial as a monotherapy in combination with anti-PD-1 checkpoint inhibitors, pembrolizumab, and nivolumab for refractory solid tumor cancers; and Phase 1 trial for the treatment of moderate to severe viral acute respiratory distress syndrome. It is also developing MiNK-215, an IL-15 armored tumor stromal targeting the FAP-CAR-iNKT program to treat solid tumors and inflammation; and MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen for auto-immune diseases. The company has collaborations with Autonomous Therapeutics to target and treat metastatic tumors; and ImmunoScape, Inc. to discover and develop T-cell receptor therapies against targets in solid tumors. The company was formerly known as AgenTus Therapeutics, Inc. and changed its name to MiNK Therapeutics, Inc. in June 2021. The company was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMiNK Therapeutics (NASDAQ:INKT) Stock Rating Upgraded by Wall Street Zen MarketBeat
Read more →MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Average Recommendation of “Hold” from Brokerages Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$39
Analyst Picks
Strong Buy
2
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 2.30% of the total shares of Mink Therapeutics Inc
1.
Vanguard Group Inc(0.525%)
since
2025/06/30
2.
Longbow Finance SA(0.3685%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(0.3278%)
since
2025/07/31
4.
Geode Capital Management, LLC(0.2541%)
since
2025/06/30
5.
Vanguard Institutional Extnd Mkt Idx Tr(0.2227%)
since
2025/07/31
6.
BlackRock Inc(0.1641%)
since
2025/06/30
7.
Fidelity Extended Market Index(0.1214%)
since
2025/07/31
8.
Fidelity Nasdaq Composite Index(0.0421%)
since
2025/07/31
9.
Fidelity Total Market Index(0.0419%)
since
2025/07/31
10.
Fidelity Series Total Market Index(0.0363%)
since
2025/07/31
11.
Spartan Extended Market Index Pool F(0.0326%)
since
2025/07/31
12.
Wells Fargo & Co(0.0188%)
since
2025/06/30
13.
Extended Equity Market Fund K(0.0182%)
since
2025/06/30
14.
NT Ext Equity Mkt Idx Fd - L(0.0162%)
since
2025/06/30
15.
Northern Trust Extended Eq Market Idx(0.0162%)
since
2025/06/30
16.
Spartan Total Market Index Pool G(0.0144%)
since
2025/07/31
17.
Bank of America Corp(0.0126%)
since
2025/06/30
18.
Total Investment Management Inc(0.0111%)
since
2025/06/30
19.
NT Ext Equity Mkt Idx Fd - NL(0.0072%)
since
2025/06/30
20.
UBS Group AG(0.0063%)
since
2025/06/30
21.
State St US Extended Mkt Indx NL Cl C(0.0062%)
since
2025/08/31
22.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0056%)
since
2025/06/30
23.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0046%)
since
2025/06/30
24.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0039%)
since
2024/12/31
25.
Covestor Ltd(0.0029%)
since
2025/06/30
26.
BNYM Mellon SL Market Completion UC1(0.0028%)
since
2025/06/30
27.
Advisor Group Holdings, Inc.(0.0027%)
since
2025/06/30
28.
SSgA U.S. Total Market Index Strategy(0.0026%)
since
2025/03/31
29.
Extended Equity Market Fund M(0.0023%)
since
2025/06/30
30.
AVIP BlackRock Advtg Small Cp Gr Prtfl(0.0021%)
since
2025/06/30
31.
BNP Paribas Arbitrage, SA(0.0006%)
since
2025/06/30
32.
Morgan Stanley - Brokerage Accounts(0.0005%)
since
2025/06/30
33.
Northwestern Mutual Wealth Management Co(0.0004%)
since
2025/06/30
34.
Game Plan Financial Advisors, LLC(0.0004%)
since
2025/06/30
35.
Hartland & Co(0.0003%)
since
2025/06/30
36.
JPMorgan Chase & Co(0.0003%)
since
2025/06/30
37.
KEY Financial, INC.(0.0001%)
since
2025/06/30
38.
JONES FINANCIAL COMPANIES LLLP(0%)
since
2025/06/30
39.
Hanson Mcclain Inc(0%)
since
2025/03/31
40.
Tower Research Capital LLC(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.65
EPS Estimate
-0.07
EPS Difference
-0.58
Surprise Percent
-828.5714%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.